Bioventus Inc.

BVS | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.31

+$0.40 (+3.10%)

At close: Sep 21, 2026, 4:00 PM ET

$13.45

+$0.14 (+1.05%)

Pre-market: Sep 22, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	568.09M	573.28M	512.35M	512.12M	430.9M	321.16M
Cost of Revenue	185.66M	185.05M	184.15M	181.04M	128.19M	87.64M
Gross Profit	382.43M	388.23M	328.19M	331.08M	302.71M	233.52M
Operating Income	58.55M	-11.98M	-81.73M	-167.23M	12.06M	21.24M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	25.71M	-49.13M	-121.11M	-189.03M	9.49M	15.91M
Net Income	22.73M	-33.54M	-156.23M	-158.7M	19.38M	16.41M
Selling & General & Admin	311.77M	327.09M	303.88M	332.13M	254.25M	193.08M
Research & Development	12.11M	13.64M	13.45M	23.85M	19.04M	11.2M
Other Expenses	n/a	59.47M	92.59M	142.33M	17.35M	8M
Operating Expenses	323.88M	400.21M	409.92M	498.31M	290.65M	212.28M
Interest Expense	26.49M	38.79M	40.68M	12.02M	1.11M	9.75M
Selling & Marketing Expenses	n/a	4.42M	3.85M	5.2M	n/a	n/a
Cost & Expenses	509.54M	585.26M	594.07M	679.35M	418.84M	299.92M
Income Tax Expense	-1.57M	-5.29M	85K	-44.37M	-1.97M	1.19M
Shares Outstanding (Basic)	66.62M	65.36M	62.65M	61.39M	45.47M	37.7M
Shares Outstanding (Diluted)	68.91M	65.36M	62.65M	61.39M	45.47M	37.7M
EPS (Basic)	0.34	-0.52	-2.49	-2.59	-0.15	0.44
EPS (Diluted)	0.33	-0.52	-2.49	-2.59	-0.15	0.44
EBITDA	99.21M	39.22M	-23.07M	-121.61M	45.48M	54.31M
EBIT	52.2M	-10.33M	-80.44M	-177M	10.6M	25.67M
Depreciation & Amortization	47.01M	49.56M	57.37M	55.4M	34.88M	28.64M